Current News

Contact | Print version | Send article | RSS feed

MedMira's Biosensor Division to Collaborate with National Research Council on Breast Cancer Research

17 Nov 2006 - MedMira Inc. announced that it has entered into a collaborative agreement with the National Research Council of Canada (NRC), through its biosensor division, Maple BioSciences. The agreement will allow NRC to work with Maple BioSciences on the discovery and validation of breast cancer biomarkers. The project will commence when the final agreement and details are completed in early 2007.
 
The NRC/Maple Biosciences partnership shall bring together research and the mapleTWO technology resulting in advanced diagnostics and additional accuracy in the classification of the various breast cancer development stages. mapleTWO, based on the SKN (scanning Kelvin nanoprobe) technology, is a sensitive tool for detecting the biomolecular interactions that form the heart of clinical diagnostics.